Zura Bio ZURA
NASDAQ ZURA
$1.43 +0.02 (+1.78%)
At close: Nov 11, 2026 · 4:00 PM EST

Zura Bio (ZURA) EBITDA (2024 - 2026)

Updated

Zura Bio (ZURA) recorded EBITDA of -$29.34 million in Q2 2026, compared with -$18.07 million a year earlier.

Analysis

Zura Bio (ZURA) EBITDA (2024 - 2026) Analysis & Trends

On a TTM basis, Zura Bio's EBITDA came in at -$92.7 million as of Jun 30, 2026; for FY2025, it was -$75.2 million.

  • Across earlier years, EBITDA came in at -$55.18 million in FY2024.
  • The Q2 2026 figure is the lowest quarterly EBITDA in data going back to Q3 2024.
  • Per Business Quant, the preceding three quarters came in at -$25.48 million (Q1 2026), -$18.4 million (Q4 2025) and -$19.49 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 8.95 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 8.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 8.16 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 7.34 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 5.99 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 4.83 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 4.20 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 7.05 Bn
10 Zura Bio 178.80 Mn -549.04 Mn - -28.77 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -28.77 Mn
Jun 30, 2026 -29.34 Mn
Mar 31, 2026 -25.48 Mn
Dec 31, 2025 -18.36 Mn
Sep 30, 2025 -19.52 Mn
Jun 30, 2025 -18.07 Mn
Mar 31, 2025 -19.25 Mn
Dec 31, 2024 -15.73 Mn
Sep 30, 2024 -19.32 Mn
API Access

Zura Bio EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda&ticker=ZURA&period=max&api_key=YOUR_API_KEY